Teresa Rushing

782 total citations
25 papers, 576 citations indexed

About

Teresa Rushing is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Genetics. According to data from OpenAlex, Teresa Rushing has authored 25 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 5 papers in Pharmacology and 5 papers in Genetics. Recurrent topics in Teresa Rushing's work include Acute Lymphoblastic Leukemia research (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Teresa Rushing is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Teresa Rushing collaborates with scholars based in United States, Canada and France. Teresa Rushing's co-authors include Michael Neely, Jill A. Hoffman, Andrea Kovács, Roger W. Jelliffe, Cathy E. Shin, W. Eric Wong, Wes Onland, Etan Orgel, Sylvain Goutelle and Nathalie Bleyzac and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Teresa Rushing

20 papers receiving 569 citations

Peers

Countries citing papers authored by Teresa Rushing

Since Specialization

Citations

This map shows the geographic impact of Teresa Rushing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa Rushing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa Rushing more than expected).

Fields of papers citing papers by Teresa Rushing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teresa Rushing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa Rushing. The network helps show where Teresa Rushing may publish in the future.

Co-authorship network of co-authors of Teresa Rushing

This figure shows the co-authorship network connecting the top 25 collaborators of Teresa Rushing. A scholar is included among the top collaborators of Teresa Rushing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresa Rushing. Teresa Rushing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	T-cell dysfunction during blinatumomab therapy in pediatric acute lymphoblastic leukemia 2025 ·Blood Advances ·(unknown), Annie Luong, Andrew Doan, (unknown), Lingyun Ji, (unknown), (unknown), Teresa Rushing, Phuong-Anh T. Duong, (unknown), Chintan Parekh	1
2	Real‐World Experience Using Sodium Thiosulfate Pentahydrate Off‐Label for Cisplatin Otoprotection in Children, Adolescents, and Young Adults 2025 ·Pediatric Blood & Cancer ·(unknown), Jennifer H. Foster, Shahrad R. Rassekh, Jemily Malvar, Yueh‐Yun Chi, (unknown), Jimin Jeon, David R. Freyer, Teresa Rushing, Etan Orgel	0
3	Calaspargase pegol and pegaspargase cause similar hepatosteatosis in mice 2024 ·Haematologica ·Verónica Ruiz-Torres, Dennis J. Chia, Michael R. Cohen, Tan Jia, Teresa Rushing, (unknown), Etan Orgel, Steven D. Mittelman	0
4	Lack of benefit from premedication for pegylated asparaginase during pediatric acute lymphoblastic leukemia/lymphoma therapy: A side‐by‐side comparison 2023 ·Pediatric Blood & Cancer ·(unknown), (unknown), (unknown), (unknown), Kasey J. Leger, Teresa Rushing, Etan Orgel	1
5	OUTC-06. BEST PRACTICES FOR THE SUCCESSFUL ADMINISTRATION OF COMBINATION METRONOMIC ANTI-ANGIOGENIC AND INTRAVENTRICULAR THERAPY 2023 ·Neuro-Oncology ·(unknown), Ashley Margol, (unknown), Nathan Robison, Teresa Rushing, Tom B. Davidson, (unknown), (unknown)	1
6	Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial 2023 ·Clinical Cancer Research ·Etan Orgel, Kristin R. Knight, Yueh‐Yun Chi, Jemily Malvar, Teresa Rushing, (unknown), Laurie S. Eisenberg, Shahrad R. Rassekh, Colin J.D. Ross, (unknown), Michael Neely, Edward A. Neuwelt, Leslie L. Muldoon, David R. Freyer	19
7	Results from the Phase 1 Portion of a Trial of Oral Ixazomib Combined with Chemotherapy in Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoma in Children, Adolescents and Young Adults: A Report from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium 2023 ·Blood ·Eric S. Schafer, Yueh‐Yun Chi, Jemily Malvar, Teresa Rushing, Andrew Doan, Holly Pacenta, Reuven J. Schore, Richard Sposto, (unknown), Paul S. Gaynon, Jeffrey E. Rubnitz, Julio C. Barredo, (unknown), Melinda Pauly, Alan S. Wayne, Deepa Bhojwani, Terzah M. Horton	0
8	Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study 2021 ·The Lancet Child & Adolescent Health ·(unknown), Chunqiao Luo, Joshua Millstein, Kristin R. Knight, Shahrad R. Rassekh, Beth Brooks, Colin J.D. Ross, Michael Wright, (unknown), Teresa Rushing, Adam J. Esbenshade, Bruce Carleton, Etan Orgel	52
9	Intra-individual Pharmacokinetic Variability of Intravenous Busulfan in Hematopoietic Stem Cell-Transplanted Children 2020 ·Clinical Pharmacokinetics ·(unknown), (unknown), Michael Neely, Teresa Rushing, Yves Bertrand, Michel Ducher, (unknown), Jérôme Guitton, Nathalie Bleyzac, Sylvain Goutelle	25
10	Improving the Timeliness of Chemotherapy Administration in the Bone Marrow Transplant Unit 2019 ·Biology of Blood and Marrow Transplantation ·Rusha Bhandari, Etan Orgel, Teresa Rushing, (unknown), (unknown), Sonata Jodele, Christopher E. Dandoy	0
11	Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi’s Sarcoma-Associated Herpesvirus Latent and Lytic Replications 2018 ·mBio ·Marion Gruffaz, Shenghua Zhou, Karthik Vasan, Teresa Rushing, (unknown), (unknown), Jae U. Jung, Shou‐Jiang Gao	15
12	Maximal concentration of intravenous busulfan as a determinant of veno-occlusive disease: a pharmacokinetic-pharmacodynamic analysis in 293 hematopoietic stem cell transplanted children 2018 ·Bone Marrow Transplantation ·(unknown), Michael Neely, Teresa Rushing, Yves Bertrand, Nathalie Bleyzac, Sylvain Goutelle	26
13	Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors 2018 ·Journal of Neuro-Oncology ·Nathan Robison, Kee Kiat Yeo, (unknown), Jemily Malvar, Michael A. Sheard, Ashley Margol, Robert C. Seeger, Teresa Rushing, Jonathan L. Finlay, Richard Sposto, Girish Dhall	11
14	Accurately Achieving Target Busulfan Exposure in Children and Adolescents With Very Limited Sampling and the BestDose Software 2016 ·Therapeutic Drug Monitoring ·Michael Neely, (unknown), Teresa Rushing, Xiaowei Fu, Michael Van Guilder, David S. Bayard, Alan Schumitzky, Nathalie Bleyzac, Sylvain Goutelle	52
15	PRELIMINARY RESULTS OF A PROSPECTIVE FEASIBILITY PILOT STUDY OF "GEMPOX" (GEMCITABINE, OXALIPLATIN, AND PACLITAXEL) IN PEDIATRIC AND ADULT PATIENTS WITH REFRACTORY OR RECURRENT CENTRAL NERVOUS SYSTEM (CNS) GERM CELL TUMORS (GCT): THE INTERNATIONAL CNS GCT CONSORTIUM TRIAL, CNS GCT-4 2014 ·Neuro-Oncology ·Jonathan L. Finlay, Yuanbo Liu, (unknown), Anat Erdreich‐Epstein, Teresa Rushing, (unknown), (unknown), Erin N. Kiehna, Mark D. Krieger, Floyd H. Gilles, (unknown), Massimo D’Apuzzo, Girish Dhall	1
16	Clinical and Microbiologic Outcomes of Quinolone Prophylaxis in Children With Acute Myeloid Leukemia 2014 ·The Pediatric Infectious Disease Journal ·Susanna Felsenstein, Etan Orgel, Teresa Rushing, Cecilia Fu, Jill A. Hoffman	26
17	Efficacy And Tolerability of Intravenous Pentamidine Isethionate For Pneumocystis Jiroveci Prophylaxis In A Pediatric Oncology Population 2013 ·The Pediatric Infectious Disease Journal ·Etan Orgel, Teresa Rushing	12
18	Voriconazole Pharmacokinetics and Pharmacodynamics in Children 2009 ·Clinical Infectious Diseases ·Michael Neely, Teresa Rushing, Andrea Kovács, Roger W. Jelliffe, Jill A. Hoffman	169
19	The Effects of Campath 1H upon Graft-Versus-Host Disease, Infection, Relapse, and Immune Reconstitution in Recipients of Pediatric Unrelated Transplants 2007 ·Biology of Blood and Marrow Transplantation ·Ami J. Shah, Neena Kapoor, Gay M. Crooks, Kenneth I. Weinberg, (unknown), (unknown), (unknown), Teresa Rushing, Donald B. Kohn, Robertson Parkman	44
20	Ethanol-Lock Technique for Persistent Bacteremia of Long-term Intravascular Devices in Pediatric Patients 2006 ·Archives of Pediatrics and Adolescent Medicine ·Wes Onland, Cathy E. Shin, (unknown), Teresa Rushing, W. Eric Wong	98

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact